Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasound

• US 5,188,106 A
• Filed: 03/08/1991
• Issued: 02/23/1993
• Est. Priority Date: 03/08/1991
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Telectronics Pacing Systems, Inc (Abbott Laboratories Incorporated)
• Inventors: Maas, Steven M., Valenta, Harry L. Jr., Nappholz, Tibor A., Koestner, Ken
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): Getzow, Scott M.
• Application Number:
  US07/675,639
• Time in Patent Office: 718 Days
• Field of Search: 128/419 PG, 128/661.07, 128/661.08, 128/661.09, 128/662.04, 128/DIG. 12, 128/DIG. 13
• US Class Current: 607/24
• CPC Class Codes: A61B 8/065 to determine blood output from the heart in general A61B5/029
• CPC Class Codes: A61B 8/08 Detecting organic movements or changes, e.g. tumours, cysts, swellings A61B8/02 - A61B8/06 take precedence
• CPC Class Codes: A61B 8/12 in body cavities or body tracts, e.g. by using catheters catheters per se A61M25/00
• CPC Class Codes: A61B 8/445 Details of catheter construction
• CPC Class Codes: A61B 8/488 involving Doppler signals
• CPC Class Codes: A61N 1/36528 the parameter being measured by means of ultrasound
• CPC Class Codes: A61N 1/36571 controlled by blood flow rate, e.g. blood velocity or cardiac output
• CPC Class Codes: Y10S 128/13 Infusion monitoring

Abstract

A hemodynamic control apparatus and method for regulating blood flow within the cardiovascular system in a closed-loop control system using ultrasound measurement techniques to determine a hemodynamic status of the patient and to derive a control parameter for modulating the hemodynamics of the system using electrical or pharmaceutical therapy. This apparatus and method provides for the monitoring of heart contractility and blood flow output from the heart to control an implantable cardiac assist or therapy device to maintain cardiac output without invading the left heart or the arterial system of the patient.

Claims

1. A hemodynamic control apparatus for determining a patient'"'"'s hemodynamic status and adjusting the hemodynamic output of the patient'"'"'s heart to correspond to the patient'"'"'s metabolic needs, comprising:

means for generating electrical stimulation pulses,

ultrasonic means implanted within the patient'"'"'s cardiovascular system for monitoring at least one parameter corresponding to the volume of blood flow per unit of time within the cardiovascular system,

means for determining cardiac performance based on said at least one monitored parameter, and

means for adjusting said pulse generating means as a function of said cardiac performance,

characterized in that said ultrasonic means is adapted to be implanted within the patient'"'"'s right heart and fixably positioned therein to ensonify the patient'"'"'s ascending aorta with ultrasonic energy such that said ultrasonic means detects returning ultrasonic energy predominantly reflected from blood cells within the ascending aorta and monitors said at least one volume of blood flow parameter.

2. A hemodynamic control apparatus in accordance with claim 1, wherein said means for adjusting said pulse generating means adjusts at least one of the pulse generation parameters from the group of pulse generation parameters comprising electrical stimulation pulse timing, electrical stimulation pulse duration, electrical stimulation pulse amplitude, electrical stimulation pulse polarity, pacing mode and pacing rate.

3. A hemodynamic control apparatus in accordance with claim 1, wherein said ultrasonic means includes ultrasonic transmitting means utilizing timed bursts of ultrasonic pulses, and ultrasonic receiving means employing Doppler measurement techniques, for monitoring said at least one parameter.

4. A hemodynamic control apparatus for determining a patient'"'"'s hemodynamic status and adjusting the hemodynamic output of the patient'"'"'s heart to correspond to the patient'"'"'s metabolic needs, comprising:

means for generating electrical stimulation pulses, said generating means including means for generating ventricular pacing pulses,

ultrasonic means implanted within the patient'"'"'s cardiovascular system for monitoring at least one parameter corresponding to the volume of blood flow per unit of time within the cardiovascular system,

means for determining cardiac performance based on said at least one monitored parameter, said means for determining cardiac performance comprising a means for deriving a cardiac performance index,

means for adjusting said pulse generating means as a function of said cardiac performance,

means for sensing atrial heartbeats,

means for determining a metabolic indicator rate as a function of blood flow per unit of time and independent of the rate of sensed natural atrial heartbeats,

means for classifying whether the sensed natural atrial heart rate is physiological or pathological based on the sensed natural atrial heart rate, the metabolic indicator rate and the cardiac performance index, and

control means operative when the sensed natural atrial heart rate is physiological for keying the operation of said ventricular pacing pulse generating means to the operation of said atrial heartbeat sensing means, and operative otherwise for keying the operation of said ventricular pacing pulse generating means to said metabolic indicator rate.

5. A hemodynamic control apparatus in accordance with claim 4, wherein said ultrasonic means comprises:

means for determining the rate of change of the blood flow volume in response to a heartbeat, and

means for deriving a cardiac contractility parameter from the rate of change of the blood flow volume, and wherein said means for determining said cardiac performance index and said means for determining said metabolic indicator rate are based on said cardiac contractility parameter.

6. A hemodynamic control apparatus in accordance with claim 4, wherein said ultrasonic means comprises:

means for integrating the blood flow velocity over time to determine cardiac output; and

wherein said means for determining said cardiac performance index and said means for determining said metabolic indicator rate are based on said cardiac output.

7. A hemodynamic control apparatus in accordance with claim 4, wherein said ultrasonic means comprises:

means for integrating the blood flow velocity over at least one cardiac cycle to determine the stroke volume, and wherein said means for determining said cardiac performance index and said means for determining said metabolic indicator rate are based on said stroke volume.

8. A hemodynamic control apparatus in accordance with claim 4, wherein said classifying means defines an atrial tracking rate which is proportional to said metabolic indicator rate, and wherein said classifying means classifies the sinus heart rate as pathological when the sensed natural atrial heart rate is faster than said atrial tracking rate and the cardiac performance index is decreasing.

9. A hemodynamic control apparatus in accordance with claim 4, wherein said ultrasonic means includes ultrasonic transmitting means utilizing timed bursts of ultrasonic pulses, and ultrasonic receiving means employing Doppler measurement techniques, for monitoring said at least one parameter.

10. A hemodynamic control apparatus in accordance with claim 4, further including:

means for determining cardiac performance index minimum value characterizing the threshold level of hemodynamic output resulting from generated ventricular pacing pulses which successfully stimulate the heart,

means for comparing subsequent cardiac performance indices resulting from ventricular pacing pulses to said cardiac performance index minimum value, and

control means responsive to said comparing means for adjusting the energy level of said generated ventricular pacing pulses to safely stimulate the heart so that the cardiac performance indices will consistently exceed the cardiac performance index minimal value.

11. A hemodynamic control apparatus for determining a patient'"'"'s hemodynamic status and adjusting the hemodynamic output of the patient'"'"'s hearts to correspond to the patient'"'"'s metabolic needs, comprising:

an implantable drug infusion pump,

ultrasonic means implanted within the patient'"'"'s cardiovascular system for monitoring at least one parameter corresponding to the volume of blood flow per unit of time within the cardiovascular system,

means for determining cardiac performance based on said at least one parameter, and

means for adjusting the timing and dosage of a pharmaceutical administered by said implantable drug infusion pump as a function of said cardiac performance.

12. A hemodynamic control apparatus in accordance with claim 11, wherein said means for determining cardiac performance comprises a means for deriving a cardiac performance index, and wherein said adjusting means further includes:

means for determining a cardiac performance index minimum value characterizing the threshold level of hemodynamic output resulting from at least one heartbeat,

means for comparing subsequent cardiac performance indices, during a predetermined time period, to said cardiac performance index minimum value, and control means responsive to said comparing means for activating and controlling the output of said drug infusion pump.

13. A hemodynamic control apparatus in accordance with claim 11, wherein said ultrasonic means is adapted to be implanted within the patient'"'"'s right heart for ensonifying the patient'"'"'s ascending aorta with ultrasonic energy and detecting returning ultrasonic energy reflected from blood cells within the ascending aorta.

14. A hemodynamic control apparatus in accordance with claim 11, wherein said cardiac performance index is based on the contractility of the heart, and wherein said adjusting means further includes:

means for determining a cardiac performance index minimum value characterizing the threshold level of hemodynamic output for supporting the needs of the body,

means for comparing subsequent cardiac performance indices, during a predetermined time period, to said cardiac performance index minimum value, and

control means responsive to said comparing means for activating and controlling the output of said drug infusion pump.

15. A hemodynamic control apparatus in accordance with claim 11, wherein said ultrasonic means includes ultrasonic transmitting means utilizing timed bursts of ultrasonic pulses, and ultrasonic receiving means employing Doppler measurement techniques, for monitoring said at least one parameter.

16. A method of operating a hemodynamic control apparatus for determining a patient'"'"'s hemodynamic status and adjusting the hemodynamic output of the patient'"'"'s heart to correspond to the patient'"'"'s metabolic needs, comprising the steps of:

generating electrical stimulation pulses,

ultrasonically monitoring at least one parameter corresponding to the volume of blood flow per unit of time within the patient'"'"'s cardiovascular system, said ultrasonically monitoring step further comprising the substeps of implanting an ultrasonic transducer within the patient'"'"'s right heart, fixably positioning the ultrasonic transducer to direct its ultrasonic energy towards the patient'"'"'s ascending aorta, ensonifying the ascending aorta with ultrasonic energy, detecting the returning ultrasonic energy predominantly reflected from blood cells within the ascending aorta and deriving at least one blood flow volume parameter from said detected returning ultrasonic energy,

determining cardiac performance based on said at least one monitored parameter,

and adjusting said electrical stimulation pulses based on said cardiac performance.

17. A method of operating a hemodynamic control apparatus in accordance with claim 16, wherein said adjusting step adjusts at least one of the pulse generation parameters from the group of pulse generation parameters comprising electrical stimulation pulse timing, electrical stimulation pulse duration, electrical stimulation pulse amplitude, electrical stimulation pulse polarity, pacing mode and pacing rate.

18. A method of operating a hemodynamic control apparatus in accordance with claim 16, wherein said step of determining cardiac performance includes the step of measuring the contractility of the heart.

19. A method of operating a hemodynamic control apparatus for determining a patient'"'"'s hemodynamic status and adjusting the hemodynamic output of the patient'"'"'s heart to correspond to the patient'"'"'s metabolic needs, comprising:

interconnecting a source of cardiovascular-active pharmaceutical with a patient'"'"'s cardiovascular system,

ultrasonically monitoring at least one parameter corresponding to the volume of blood flow per unit of time within the patient'"'"'s cardiovascular system, determining cardiac performance based on said at least one monitored parameter, and

adjusting the timing and dosage of the pharmaceutical introduced into the patient'"'"'s cardiovascular system based on said cardiac performance.

20. A method of operating a hemodynamic control apparatus in accordance with claim 19, wherein said step of determining cardiac performance comprises a step of deriving a cardiac performance index, and wherein said adjusting step further includes the substeps of:

determining a cardiac performance index minimum value characterizing the threshold level of hemodynamic output resulting from at least one heart beat,

comparing subsequent cardiac performance indices, during a predetermined time period, to said cardiac performance index minimum value, and

adjusting the timing and dosage of the pharmaceutical introduced into the patient'"'"'s cardiovascular system in response to the results of said comparing step.

21. A method of operating a hemodynamic control apparatus in accordance with claim 20, wherein said step of ultrasonically monitoring at least one parameter corresponding to the volume of blood flow per unit of time within the patient'"'"'s cardiovascular system includes the steps of ensonifying the ascending aorta with ultrasonic energy and detecting the returning ultrasonic energy reflected from blood cells within the ascending aorta.

22. A method of operating a hemodynamic control apparatus in accordance with claim 19, wherein said step of deriving a cardiac performance index includes the step of measuring the contractility of the heart.